No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators
| dc.contributor.author | Price, David | |
| dc.contributor.author | Henley, William | |
| dc.contributor.author | Carter, Victoria | |
| dc.contributor.author | Skinner, Deborah | |
| dc.contributor.author | Vella, Rebecca | |
| dc.contributor.author | Papi, A. | |
| dc.contributor.author | Fabbri, L M | |
| dc.contributor.author | Kertsjens, H | |
| dc.contributor.author | Roche, Nicolas | |
| dc.contributor.author | Singh, Dave | |
| dc.contributor.author | Vogelmeier, C | |
| dc.contributor.author | Sen, E | |
| dc.contributor.author | Cancado, J | |
| dc.contributor.author | Nudo, Elena | |
| dc.contributor.author | Barile, Sara | |
| dc.contributor.author | Georges, George | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-04-25T15:33:00Z | |
| dc.date.available | 2024-04-25T15:33:00Z | |
| dc.date.issued | 2022-03-16 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 2 | |
| dc.format.extent | 106529 | |
| dc.identifier | 289089704 | |
| dc.identifier | 02a5cd42-4225-4fb1-b69c-5c1aecbc2d90 | |
| dc.identifier.citation | Price, D, Henley, W, Carter, V, Skinner, D, Vella, R, Papi, A, Fabbri, L M, Kertsjens, H, Roche, N, Singh, D, Vogelmeier, C, Sen, E, Cancado, J, Nudo, E, Barile, S & Georges, G 2022, 'No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators', Respirology, vol. 27, no. S1, TO 016, pp. 28-29. https://doi.org/10.1111/resp.14216 | en |
| dc.identifier.doi | 10.1111/resp.14216 | |
| dc.identifier.issn | 1323-7799 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23348 | |
| dc.identifier.vol | 27 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Respirology | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Price_etal_TSANZSRS_No_Difference_In_AAM.pdf
- Size:
- 104.03 KB
- Format:
- Adobe Portable Document Format
